Alisa Kirkin

Immune signatures could predict adverse events from immunotherapy, paving the way for personalized cancer treatment strategies.

Researchers at the University of Colorado Boulder have developed a groundbreaking handheld diagnostic device that could deliver blood test results within an hour using just a finger-prick sample.

Physicians will now be able to order Myriad Genetics' MyRisk Hereditary Cancer Test and view the results of the test directly in Flatiron Health's

Innovative research from the University of Ottawa suggests that edaravone, a drug currently used to treat amyotrophic lateral sclerosis (ALS), could

A healthy diet may reduce the chance of low risk prostate cancer progressing in men undergoing active surveillance.

The U.S. National Institutes of Health has launched a unique portfolio of biomarker-driven precision medicine clinical trials, known as myeloMATCH, that will test new treatments for patients with myeloid cancers.

A research team led by Ho Sang Jung, PhD, at the Korea Institute of Materials Science has developed a promising new method for diagnosing cancer that could transform early detection efforts.

A recent study led by researchers at Northwestern University Feinberg School of Medicine says it is now possible to predict within three days of

A robotic system can microinject individual heart cells between beats and could help identify potential treatments for cardiac arrhythmias , study findings suggest.

In the latest deal for the red-hot radiopharmaceutical field, Alpha-9 Oncology announced an oversubscribed $175 million series C financing to support advancement of its pipeline.